SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is experiencing extreme volatility as investors weigh mixed Q2 earnings results, a revenue miss, and cautious future guidance against the stock's recent multi-year price lows. The community remains deeply divided, with some traders anticipating a long-term recovery supported by ad-tier monetization, while others aggressively short the stock, citing a saturated subscriber base and intense competition from platforms like YouTube.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is facing intensified market scrutiny and volatility following reports of delays to its Gemini 3.5 Pro model, with investors closely watching for signs of AI execution bottlenecks and potential shifts in infrastructure spending. Despite the near-term downward pressure, the community remains actively divided, with many traders debating whether this is a prime buy-the-dip opportunity for a dominant tech leader or a signal that AI hype is beginning to face a reality check.

Oracle Corporation. The Group's principal activities are to develop, manufacture, market, distribute and service computer software. It has two businesses, software and services, which are further divided into five segments. Its software business consist of two segments: The new software license segment is engaged in the licensing of database, middleware software and applications software.The software license updates and product support segment provides customers with rights to unspecified software product upgrades and maintenance releases, internet access to technical content, internet and telephone access to technical support personnel. Its services business is comprised of three segments: The consulting segment provides services in business strategy and analysis, business process simplification, solutions integration and the implementation, enhancement and upgrade of database, middleware and applications software. On Demand includes Oracle On Demand and Advanced Customer Services.

Oracle Corp.

Oracle is experiencing significant downward pressure as market participants debate its massive data center capital expenditures and heavy debt load, leading to intense volatility and capitulation from retail investors. The community remains deeply divided, with bears pointing to the lack of insider buying and potential dilution as signs of a fundamental decline, while bulls view the pullback as a generational buying opportunity based on the company's long-term cloud and AI infrastructure growth.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is experiencing significant volatility following a double beat on earnings, with the community divided between long-term confidence in its robotic surgery dominance and skepticism regarding its high valuation. Investors are actively debating the impact of increased procedure growth against margin pressures and the potential for a reversal as the stock navigates a complex technical environment.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk Corp is facing significant volatility and intense selling pressure as investors rotate out of high-growth semiconductor stocks amid broader sector concerns. The community remains deeply divided, with some traders debating whether this deep correction offers a strategic buying opportunity or if the stock is vulnerable to further downside as bearish momentum persists.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending as investors digest strong quarterly results and raised full-year earnings guidance, driving significant bullish sentiment. The stock is being closely monitored by the community as a key healthcare leader, with ongoing discussions centered on potential institutional rotation into the sector and the company's ability to maintain upward momentum despite broader market volatility.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Invesco QQQ Trust is experiencing heightened volatility as the market debates the sustainability of the AI-driven rally, with community sentiment deeply divided between those anticipating a major correction and those betting on a swift reversal. Traders are closely monitoring a mix of geopolitical tensions, earnings reports, and speculative options positioning, as market participants grapple with shifting economic expectations and uncertainty surrounding upcoming political commentary.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is facing intense downward pressure as investors rotate out of high-beta AI infrastructure stocks, overshadowing recent announcements regarding a new asset-light business model and major compute agreements. While the community remains deeply divided between those viewing the pullback as a prime buying opportunity and others expressing concerns over valuation and sector-wide volatility, the stock is testing critical technical support levels.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is currently a major focus for traders as the community debates whether the recent intense volatility and aggressive sell-off represent a final bottom or a deeper structural decline. Sentiment is sharply divided between those aggressively buying the dip in anticipation of a massive rebound driven by AI and data center infrastructure demand, and those warning that the sector is caught in a forced deleveraging cycle.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as investors rally behind renewed optimism for its AI strategy and ecosystem, driving the stock to new highs despite competing narratives regarding hardware versus infrastructure demand. Community sentiment is deeply divided between those viewing the move as a sustainable breakout fueled by service growth and AI potential, and those calling the rapid appreciation a manipulated scam driven by liquidity management and institutional positioning.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors

Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors PR Newswire CAMBRIDGE, Mass., July 15, 2026 CAMBRIDGE, Mass., July 15, 2026 /PRNewswire/ -- Decoy Therapeutics Inc. (Nasdaq: DCOY), a...

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers

Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 284.8% to $11.39 during Monday's regular session. The company's market cap stands at $1.9 million.
Decoy Therapeutics (NASDAQ:DCOY) sharesread more...

DCOY Stock Nearly Doubled In Value Today – What’s Driving This Mega Rally?

Equity

Decoy Therapeutics has secured funding to begin clinical trials for its programs targeting respiratory illnesses.


Decoy Therapeutics Secures Milestone-Based Financing to Advance Antiviral Pipeline

Decoy Therapeutics (NASDAQ:DCOY) announced a private investment in public equity (PIPE) financing that could provide the biotechnology company with up to approximately $21 million in gross proceeds through a combination of upfront funding and milestone-based warrant exercises. The initial closing is expected to generate approximately $3.5 million, with additional capital becoming available if specified clinical, regulatory, and shareholder approval milestones are achieved. The company said it intends to use the proceeds to advance its lead antiviral candidate into clinical trials.

4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones

As the second half of 2026 begins, a series of regulatory approvals, strategic acquisitions, clinical development milestones, and financing initiatives are highlighting continued activity across the biotechnology and healthcare sectors, as companies work to expand pipelines, strengthen balance sheets, and advance toward commercialization. $UPC, $NTHI, $DCOY, $VRDN

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers

Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 159.6% to $7.68 during Monday's pre-market session. The company's market cap stands at $1.9 million.
Decoy Therapeutics (NASDAQ:DCOY) stockread more...

Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing

Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing PR Newswire HOUSTON, June 26, 2026 HOUSTON, June 26, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (NASDAQ: DCOY) (the "Company" or...

Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London

Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London PR Newswire CAMBRIDGE, Mass., June 8, 2026 Rick Pierce to join speakers from Boehringer Ingelheim, RA Capital and ILiAD Biotechnologies for...

Decoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors

Decoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors Decoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors PR Newswire CAMBRIDGE, Mass., June 3, 2026 CAMBRIDGE, Mass., June 3, 2026...

Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV Candidate into the Clinic

Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV Candidate into the Clinic Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV Candidate into the Clinic PR Newswire CAMBRIDGE, Mass., June 1, 2026 Collaboration supports Phase 1 and Phase 2a human proof-of-concept studies for new...

Decoy Therapeutics, Inc. operates as a preclinical-stage biotechnology company. It engages in leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company was founded by Frederick E. Pierce, Barbara Hibner, Peter Marschel, Michael Lipp, and Jodi Cooper in 2020 and is headquartered in Houston, TX.

Decoy Therapeutics Inc.

Neutral Sentiment

Memory - $MU, $SNDK, $STX, $SKHY, etc.

Neoclouds - $NBIS, $CRWV, $IREN, $APLD, etc.

Space - $RKLB, $SPCX, $ASTS, $VOYG, etc.

Neoclouds, space, and memory are among the market's most beaten-down sectors over the past week - all trading well off their recent highs despite strong underlying demand. Which are you most interested in buying right now? Explain your reasoning in the comments.

Which beaten-down industry are you most interested in adding exposure to?

Feed

News

Sentiment

Fundamentals

Info

DCOYDecoy Therapeutics Inc.

Fundamentals

Latest DCOY News